Aptevo Therapeutics Inc share price logo

Aptevo Therapeutics Inc Share Price

NASDAQ: APVO

Small Cap

$4.26

-0.23

(-5.12%)

as on

Aptevo Therapeutics Inc Stock Performance

as on March 25, 2026 at 6:58 am IST

  • Day's High

    $4.26
    $4.50

    5.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.95
    $1,299.60
    downward going graph

    7.28%

    Downside

    30407.04%

    Upside

    downward going graph

Aptevo Therapeutics Inc share price movements today

Previous Close
$4.49
Open
$4.50
Volume
146.7K
Day's Low - High
$4.26 - $4.50
52 Week Low - High
$3.95 - $1,299.60

Aptevo Therapeutics Inc Historical Returns

1 Month Return
-37.38 %
3 Month Return
-73.18 %
1 Year Return
-99.3 %
3 Year Return
-100 %
5 Year Return
-100 %

Aptevo Therapeutics Inc Stock Fundamentals & Key Indicators

Check Aptevo Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.1M

EPS (TTM)

-96.91

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

Industry PE ratio

0

PEG Ratio

0

EBITDA

-26.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-242.74%

Aptevo Therapeutics Inc Stock Valuation

Track how Aptevo Therapeutics Inc P/E has moved over time to understand its valuation trends.

Aptevo Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-12.34x)

September 30, 2024

Industry (0.00x)

March 25, 2026

Today (0.00x)

March 25, 2026

Highest (-0.14x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.00x

Aptevo Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aptevo Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Aptevo Therapeutics Inc image
Aptevo Therapeutics Inc
BUY$7.1M-100%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for Aptevo Therapeutics Inc Stock including INR - Dollar returns

The Aptevo Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Aptevo Therapeutics Inc investment value today

Current value as on today

₹10,202

Returns

₹89,798

(-89.8%)

Returns from Aptevo Therapeutics Inc Stock

₹99,339 (-99.34%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Aptevo Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Aptevo Therapeutics Inc. Average target price of $21

Aptevo Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Aptevo Therapeutics Inc.

What analysts predicted

79.71%UPSIDE

Target Price

$21

Current Price

$4.26

Analyzed by

8 Analysts

Target

$21.00

Aptevo Therapeutics Inc target price $21, a slight upside of 79.71% compared to current price of $4.26. According to 8 analysts rating.

Aptevo Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Aptevo Therapeutics Inc Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

Aptevo Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-8
-6
-6
-6
-6
-5
-6
-6
-6
-7
EBITDA
-8
-6
-6
-6
-5
-5
-6
-6
-6
-7
Interest Expense
-
-
9
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-6
-6
-6
-5
-5
-6
-6
-6
-7
Income Tax Expense
0
0
0
0
0
-
-
-
-
-
Net Income
-7
-6
-5
-6
-5
-5
-6
-6
-6
-7
Net Profit Margin
0.00%
0.00%
-654.43%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Aptevo Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
33
36
14
23
32
4
12
3
-
-
Gross Profit
16
12
9
11
-2
-13
12
3
0
0
Operating Income
-61
-126
-53
-51
-40
-27
-21
-28
-28
-24
EBITDA
-58
-64
-48
-49
-40
-26
-20
-27
-28
-23
Interest Expense
-
-
-
-
-
-
7
35
-
-
Depreciation
-
-
3
2
2
1
1
0
0
0
Income Before Tax
-61
-127
-55
-53
-43
-30
-29
7
-18
-24
Income Tax Expense
-2
-15
-23
-23
-2
-12
-2
-35
-1
-
Net Income
-59
-112
6
-53
-44
-17
-27
8
-17
-24
Net Profit Margin
-176.53%
-308.54%
47.57%
-232.75%
-137.85%
-411.93%
-222.20%
257.77%
0.00%
0.00%

Aptevo Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-6
-6
-6
-5
-5
-6
-6
-6
-7
Operating Cash Flow
-6
-5
-6
-6
-5
-5
-6
-7
-6
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
4
3
0
3
4
6
-
14
18
Change in Cash
-1
-2
-6
-2
0
0
-6
7
11

Aptevo Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-112
6
-53
-40
-17
-28
8
-17
-24
Operating Cash Flow
-36
-41
-51
-42
-29
-21
-21
-11
-23
Investing Cash Flow
-47
29
72
4
28
0
0
-
-
Financing Cash Flow
89
9
0
20
23
26
-2
5
15
Change in Cash
5
-2
20
-18
22
3
-23
-5
-8

Global Institutional Holdings in Aptevo Therapeutics Inc

Funds
Holdings
SBI Securities Co Ltd
0%
Morgan Stanley - Brokerage Accounts
0%
Virtu Financial LLC
0.21%
Advisor Group Holdings, Inc.
0.04%
JPMorgan Chase & Co
0%
See all

Aptevo Therapeutics Inc News & Key Events

    Insights on Aptevo Therapeutics Inc

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Aptevo Therapeutics Inc has experienced a drawdown of -100.0%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 89.8%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.1% return, outperforming this stock by 115.4%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 1 month, APVO stock has moved down by -37.4%

    About Aptevo Therapeutics Inc

    aptevo therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. we leverage the innovative adaptir™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. based in seattle, washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. as a result, aptevo has been able to attract some of the most innovative minds in the field. many of our team members have notable experience with other pioneering biotech companies including trubion, zymogenetics, immunex, dendreon, and vlst. at aptevo therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning aptevo therapeutics to develop the science of what’s next in biotechnology.
    OrganisationAptevo Therapeutics Inc
    Headquarters2401 4th Avenue, Seattle, WA, United States, 98121
    IndustryHealth Technology
    CEOMr. Marvin L. White
    E-voting on sharesClick here to vote

    Key Management of Aptevo Therapeutics Inc

    Name

    Title

    Dr. Dirk Huebner M.D.

    Chief Medical Officer

    Mr. Marvin L. White

    President, CEO & Director

    Mr. Jeffrey G. Lamothe CA

    Executive VP & COO

    Ms. SoYoung Kwon J.D., LL.M.

    Corporate Secretary, Senior VP, General Counsel, Business Development & Corporate Affairs

    Ms. Daphne L. Taylor CPA

    Senior VP & CFO

    FAQs

    What is Aptevo Therapeutics Inc share price today?

    Aptevo Therapeutics Inc share price today is $4.26 as on at the close of the market. Aptevo Therapeutics Inc share today touched a day high of $4.5 and a low of $4.26.

    What is the 52 week high and 52 week low for Aptevo Therapeutics Inc share?

    Aptevo Therapeutics Inc share touched a 52 week high of $1,299.6 on and a 52 week low of $3.95 on . Aptevo Therapeutics Inc stock price today i.e. is closed at $4.26,which is 99.67% down from its 52 week high and 7.85% up from its 52 week low.

    What is Aptevo Therapeutics Inc's market capitalisation today?

    Aptevo Therapeutics Inc market capitalisation is $0.00T as on .

    How to invest in Aptevo Therapeutics Inc Stock (APVO) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Aptevo Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aptevo Therapeutics Inc Shares that will get you 0.3521 shares as per Aptevo Therapeutics Inc share price of $4.26 per share as on March 25, 2026 at 1:28 am IST.

    What is the minimum amount required to buy Aptevo Therapeutics Inc Stock (APVO) from India?

    Indian investors can start investing in Aptevo Therapeutics Inc (APVO) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹937.34 in Aptevo Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Aptevo Therapeutics Inc share’s latest price of $4.26 as on March 25, 2026 at 1:28 am IST, you will get 2.3474 shares of Aptevo Therapeutics Inc. Learn more about fractional shares .

    What are the returns that Aptevo Therapeutics Inc has given to Indian investors in the last 5 years?

    Aptevo Therapeutics Inc stock has given -100% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?